Rectal Cancer
974
180
228
366
Key Insights
Highlights
Success Rate
85% trial completion
Published Results
84 trials with published results (9%)
Research Maturity
366 completed trials (38% of total)
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
6.7%
65 terminated out of 974 trials
84.9%
-1.6% vs benchmark
8%
79 trials in Phase 3/4
23%
84 of 366 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 366 completed trials
Clinical Trials (974)
Safety of Mid and Low Rectal Cancer Surgery Without Dissection of the No.253 Lymph Node (S-M-O-O-T-H)
Dynamic Contrast Enhanced Ultrasound for Predict and Assess Rectal Cancer Response After Neo-adjuvant Chemoradiation - RECT
Learning Curve of SILS in CRC
Aerobic Exercise and Guided Imagery in Low Anterior Resection Syndrome
A Phase I-II Study to Test the Safety and Efficacy of PD1 (AB122) and Adenosine Receptor (AB928) Antagonists With Chemotherapy After Short-Course Radiation for Rectal Cancer.
Total Meso-rectal Excision Versus Transanal Local Excision Followed by Radiotherapy for T2N0M0 Distal Rectal Cancer
A Study of CTX-009 in Adult Patients With Metastatic Colorectal Cancer
A Study of Atezolizumab With or Without Tiragolumab Following Neoadjuvant Chemoradiotherapy in Participants With Locally Advanced Rectal Cancer
Combining DCSZ11 With Radiation and Chemotherapy as Neoadjuvant Treatment for pMMR Locally Advanced Rectal Cancer
Ultra-fractionated Radiotherapy for Rectal Cancer
Neoadjuvant Short-Course Radiotherapy Followed by CAPOX Plus PD-1 Antibody and IL-2 in Locally Advanced Rectal Cancer (PRIDE01)
Study on the Efficacy and Safety of Neoadjuvant Radiotherapy Combined With Tislelizumab, Liposomal Irinotecan, and Capecitabine in the Treatment of pMMR Locally Advanced Rectal Adenocarcinoma With Low Rectal Involvement
Watchful Waiting for Complete Responders to Therapy in Rectal Cancer
Treatment of Adenocarcinoma of the Rectum With Transanal Local Excision for Complete Responders
Ovarian-Sparing Adaptive Radiotherapy in Young Adult Women
Autologous Fecal Microbiota Transplantation for Anal Function Recovery After Ileostomy Reversal in Rectal Cancer
Washington University Participant Engagement and Cancer Genomic Sequencing Center (WU-PE-CGS)
Neoadjuvant Chemotherapy, Excision And Observation vs Chemoradiotherapy For Rectal Cancer
Safety and Efficacy of CEA-targeted CAR-T for CEA-positive Advanced Malignant Solid Tumors
SCARLET - Italian proSpeCtionAl obseRvationaL multicEntre Study on Treatment for recTal pT1 Cancer